Stryker Non Us — Net Sales increased by 1.2% to $1.49B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.3%, from $1.39B to $1.49B. Over 3 years (FY 2021 to FY 2024), Non Us — Net Sales shows an upward trend with a 5.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests successful global expansion and growing demand for the company's products in international markets, while a decrease may indicate competitive pressure, currency headwinds, or regulatory challenges abroad.
This metric represents the total revenue generated by the company from operations and sales outside of its primary domes...
Peers in the medical device industry typically report this as 'International Revenue' or 'Revenue by Geography,' with variations depending on whether they include or exclude currency impact.
syk_segment_international_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.19B | $1.14B | $1.28B | $1.17B | $1.18B | $1.12B | $1.34B | $1.27B | $1.29B | $1.23B | $1.46B | $1.33B | $1.38B | $1.39B | $1.56B | $1.43B | $1.47B | $1.49B |
| QoQ Change | — | -4.4% | +12.4% | -8.8% | +1.0% | -5.3% | +19.7% | -5.5% | +1.5% | -4.2% | +18.5% | -8.9% | +3.5% | +0.7% | +12.9% | -8.8% | +2.9% | +1.2% |
| YoY Change | — | — | — | — | -1.0% | -1.9% | +4.4% | +8.2% | +8.7% | +10.0% | +8.9% | +5.0% | +7.0% | +12.5% | +7.1% | +7.3% | +6.8% | +7.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.